Hematocrit

Your hematocrit tells you something deceptively simple: what fraction of your blood is red blood cells versus liquid plasma. That single percentage, though, carries an outsized amount of information. Too low, and your tissues may be starving for oxygen. Too high, and your blood becomes thick enough to raise your risk of clots, heart attack, and stroke. The sweet spot in the middle is where your cardiovascular system runs most efficiently.

Multiple large studies following tens of thousands of people over decades have found a U-shaped relationship between hematocrit and mortality. Both ends of the spectrum are dangerous. Knowing where you fall on that curve, and watching how your number moves over time, gives you a window into cardiovascular risk, iron status, hydration, bone marrow function, and kidney health that no other single number provides as directly.

What Hematocrit Actually Measures

Hematocrit (HCT) is expressed as a percentage. If your hematocrit is 42%, it means 42% of your blood volume is packed with red blood cells, while the remaining 58% is plasma (the liquid portion carrying proteins, electrolytes, and hormones). Red blood cells are produced in your bone marrow under the direction of a hormone called erythropoietin, which is made primarily by your kidneys. When your tissues need more oxygen, your kidneys release more erythropoietin, which tells the bone marrow to ramp up red blood cell production.

Because hematocrit is a ratio, it can change in two ways: by gaining or losing red blood cells, or by gaining or losing plasma. This is why dehydration can make your hematocrit look high (less plasma, same red cells) and why pregnancy can make it look low (more plasma, same red cells). Understanding this distinction is key to interpreting your results correctly.

Heart Disease and Stroke Risk

The relationship between hematocrit and cardiovascular events is not linear. It follows a U-shaped or J-shaped curve, meaning risk is elevated at both the low and high ends. The Framingham Heart Study tracked over 5,200 men and women for 34 years and found that the highest quintile of hematocrit was associated with increased risk of cardiovascular death, heart attack, angina, stroke, and claudication (leg pain from poor circulation). Women also showed increased cardiovascular risk at the low end, forming a U-shaped curve.

A study of nearly 50,000 adults in Iran confirmed this U-shaped pattern, with both low and high hematocrit tied to increased overall and cardiovascular mortality. The association held even after excluding smokers and adjusting for lifestyle and medical history. In a Japanese community study of about 2,600 adults followed for 19 years, both the lowest and highest quartiles of hematocrit were linked to increased ischemic stroke risk (strokes caused by blocked blood flow to the brain), with the highest quartile carrying about 60% greater risk compared to the third quartile.

What this means for you: if your hematocrit sits in either tail of the distribution, your cardiovascular risk is elevated regardless of how your other markers look. This is why trending your hematocrit over time matters more than any single reading.

High Hematocrit and Blood Clotting

When your blood carries too many red blood cells, it becomes thicker (more viscous), which slows flow and raises the odds of clots forming. A large Scandinavian study of over 1.5 million blood donors found that men with hemoglobin at or above 17.5 g/dL (which corresponds to an elevated hematocrit) were about 3.5 times as likely to have a heart attack and about 2.4 times as likely to have an ischemic stroke compared to the reference group. Women with hemoglobin at or above 16.0 g/dL showed similarly elevated risks.

The Copenhagen General Population Study of over 108,000 individuals found that those in the top 5% of hematocrit had about 46% higher risk of heart-related blood clots, though the link to brain clots did not reach statistical significance. Interestingly, high hematocrit was not associated with venous blood clots (like deep vein thrombosis), suggesting the risk is specific to arterial events.

Heart Failure

The Framingham Heart Study also examined hematocrit and heart failure risk in over 3,500 people followed for 20 years. They found a linear increase in heart failure risk across rising hematocrit categories. Even hematocrit values within the normal range were associated with higher heart failure risk compared to the lowest category. Those in the highest hematocrit group had about 78% greater risk of developing heart failure.

Low Hematocrit: Anemia and What It Signals

A low hematocrit means your blood is carrying fewer red blood cells than expected, which reduces your body's ability to deliver oxygen to tissues. The most common cause worldwide is iron deficiency, which can result from inadequate dietary intake, poor absorption, or blood loss. In men and postmenopausal women, iron deficiency anemia should always prompt investigation for gastrointestinal bleeding. Studies show that 6% of men with iron deficiency anemia were diagnosed with gastrointestinal cancer within 2 years, and 11% of those referred for endoscopy had colorectal cancer.

In premenopausal women, heavy menstrual bleeding is the leading cause, affecting roughly half of women with heavy periods. Other causes of low hematocrit include chronic kidney disease (the kidneys produce less erythropoietin as they decline), chronic inflammation (which traps iron inside cells and suppresses red blood cell production), and bone marrow disorders.

The Oxygen Delivery Paradox

A common assumption is that higher hematocrit always means better oxygen delivery. The evidence says otherwise. While more red blood cells increase the blood's oxygen-carrying capacity, they also thicken the blood, which slows flow through tiny capillaries. Research on this trade-off shows that an optimal hematocrit range exists (typically between 30% and 50%, depending on conditions) that maximizes the amount of oxygen actually reaching tissues. Above that range, the negative effect of thicker blood outweighs the benefit of extra red cells. This is why transfusing blood to raise hematocrit in moderately anemic patients does not always improve oxygen delivery and can sometimes worsen outcomes.

Reference Ranges

Hematocrit values differ by sex due to the effects of testosterone on red blood cell production, and they shift with age. The ranges below are drawn from multiple large population studies and cardiovascular outcome data. Your lab may use slightly different cutpoints depending on the analyzer used, but the general framework is consistent.

These tiers are drawn from published research, including the Hisayama Study, the Glasgow Blood Pressure Clinic Study, and WHO/NCCN diagnostic criteria. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend. Ethnicity also matters: people of African descent tend to have lower baseline hematocrit values, with alpha-thalassemia (a common inherited trait) accounting for roughly one-third of the difference compared to white populations.

When Results Can Be Misleading

Because hematocrit is a ratio of red cells to total blood volume, anything that shifts your plasma volume will change the number without changing your actual red blood cell supply. Dehydration is the single most common cause of a falsely elevated hematocrit. In one study, hypovolemic (dehydrated) patients showed hematocrit values 4 to 5 percentage points higher than their true levels. Conversely, pregnancy causes a normal expansion of plasma volume that dilutes red blood cells and lowers hematocrit without any actual loss of red cell mass.

Several medications shift hematocrit as a side effect without indicating the conditions this test is designed to detect. ACE inhibitors and ARBs (common blood pressure medications) lower hematocrit by 1 to 6 percentage points through their effect on erythropoietin production. Metformin, widely used for diabetes, causes early decreases in hemoglobin and hematocrit within the first six months. Calcium channel blockers also reduce hematocrit with prolonged use. If you take any of these medications, your result may underestimate your true red blood cell status.

Timing and posture matter too. Hematocrit is higher in the morning and lower in the afternoon, with values falling gradually throughout the day. Sitting upright produces higher readings than lying down. Eating a meal can lower hematocrit for up to six hours. For the most comparable results, have your blood drawn in the morning, after fasting or a light breakfast, and after sitting for at least 30 minutes. Intense exercise causes a sharp but brief spike (up to 9-12%) within the first minute of stopping, which resolves within 30 minutes. Wait at least 24 hours after intense exercise before testing.

Very high blood sugar (above 800 mg/dL) can produce falsely elevated automated hematocrit readings because red blood cells swell in the analyzer. Low albumin levels (common in liver disease) can cause falsely low readings on point-of-care devices. If your result seems inconsistent with how you feel or with other lab values, a repeat test under standardized conditions is warranted.

Tracking Your Trend

Hematocrit has a within-person coefficient of variation (a measure of how much a healthy person's value naturally fluctuates) of about 3%. That makes it one of the more stable blood tests available and well-suited to serial tracking. Two successive measurements are generally enough to confirm whether a change is real or just normal fluctuation. The threshold for a clinically meaningful change between two readings is about 12% relative change (for example, moving from 44% to about 39% or 49%).

One caveat: seasonal variation can add up to 3% difference between summer (lower, due to mild hemodilution in warm weather) and winter (higher). If you test only once a year, try to do it at the same time of year for the cleanest comparison. For a baseline, get tested once. If you are making changes to diet, supplementation, or exercise, retest in 3 to 6 months. After that, annual monitoring is sufficient for most people, with more frequent checks if you are managing a condition like chronic kidney disease, taking testosterone, or monitoring polycythemia vera.

Hematocrit vs. Hemoglobin

Many people assume hematocrit and hemoglobin are interchangeable, but studies show they disagree more often than expected. In analyses of children and pregnant women, about 40-50% of anemia cases were identified by only one of the two tests, not both. Hemoglobin is generally the more reliable and specific marker for anemia: in a study of Naval Aviation personnel, hemoglobin was a statistically significant predictor of anemia (with about 10.5 times higher odds), while hematocrit was not. The commonly assumed 3:1 ratio between hematocrit and hemoglobin (hematocrit percentage equals three times hemoglobin in g/dL) is unreliable, particularly in children and certain disease states.

Both tests are included in every standard complete blood count, so you will get both automatically. But when interpreting your results, pay closer attention to hemoglobin for anemia screening and use hematocrit for its unique value as a cardiovascular risk indicator and a monitor for conditions like polycythemia vera, where maintaining hematocrit below 45% has been shown to cut cardiovascular events by roughly fourfold.